Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HPV vaccine education trial aims to overcome parental hesitancy

NCT ID NCT07447245

Knowledge-focused Sponsor: KTO Karatay University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests whether educating parents about HPV and the vaccine increases their intention to vaccinate their children. Researchers will assess parents' knowledge before and after an educational session. The trial involves 52 parents of children aged 11-18 in Turkey, where the HPV vaccine is not yet part of the national immunization program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Education about HPV vaccination
What this could lead to
If successful, this could show that a simple education program boosts parents' willingness to vaccinate their children against HPV, potentially increasing vaccination rates.
What could go wrong
This is a very small trial (52 participants) and only measures intention, not actual vaccination. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Feb 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 49 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Parent aged 18-49 years * Being a parent of a child aged 9-14 years * Being able to read and write in Turkish * Having no hearing or communication problems that would prevent participation in the educational session * Providing voluntary informed consent to participate in the study Exclusion Criteria: • Having a child who had received any dose of the HPV vaccine before enrollment in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV (human papillomavirus)-associated are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV (human papillomavirus)-associated

Contacts and locations

Locations

  • Özel Bilgi Dünyası Etüt Merkezi

    Konya, 42020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.